Alder BioPharmaceuticals® Reports Third Quarter 2018 Financial and Operating Results
- Biologics License Application (BLA) submission on track for Q1 2019 - - Robust manufacturing package for BLA submission to include positive results from pharmacokinetic comparability study - - Conference call today at 5:00 p.m. ET - BOTHELL, Wash., Nov …